Bryan L Roth Selected Research

Serotonin 5-HT2 Receptor Agonists

10/2017	5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.
1/2016	In Vitro and In Vivo Characterization of the Alkaloid Nuciferine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bryan L Roth Research Topics

Disease

28	Schizophrenia (Dementia Praecox) 01/2021 - 12/2001
13	Pain (Aches) 10/2022 - 01/2005
7	Catalepsy 10/2017 - 06/2006
6	Obesity 01/2018 - 12/2001
6	Psychotic Disorders (Schizoaffective Disorder) 01/2014 - 01/2004
5	Parkinson Disease (Parkinson's Disease) 01/2021 - 12/2008
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2011 - 09/2002
4	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2016
4	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2005
4	Neoplasms (Cancer) 01/2017 - 02/2009
4	Heart Valve Diseases (Valvular Heart Disease) 11/2011 - 06/2003
3	Neuralgia (Stump Neuralgia) 12/2021 - 11/2013
3	COVID-19 01/2021 - 01/2020
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019 - 12/2008
3	Hallucinations (Hallucination) 01/2015 - 06/2013
3	Mental Disorders (Mental Disorder) 01/2012 - 10/2006
3	Weight Gain 04/2011 - 03/2003
2	Leukemia 01/2022 - 01/2011
2	Hypersensitivity (Allergy) 12/2021 - 11/2013
2	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 01/2014
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 02/2006
2	Infections 01/2020 - 11/2004
2	Hyperglycemia 01/2019 - 03/2003
2	Carcinogenesis 01/2019 - 07/2014
2	Migraine Disorders (Migraine) 01/2018 - 06/2015
2	Schistosomiasis (Bilharziasis) 12/2017 - 01/2016
2	Prader-Willi Syndrome (Syndrome, Prader-Willi) 02/2017 - 08/2010
2	Hyperalgesia 01/2016 - 11/2013
2	Chronic Pain 01/2016 - 12/2001
2	Anxiety Disorders (Anxiety Disorder) 02/2014 - 05/2010
2	Neurodevelopmental Disorders 12/2011 - 03/2010
2	Dementia (Dementias) 03/2011 - 09/2002
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2011 - 06/2008
2	Glioma (Gliomas) 11/2009 - 08/2004
2	Hypertension (High Blood Pressure) 07/2009 - 03/2003
2	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 10/2005 - 12/2001
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Treatment-Resistant Depressive Disorder 01/2022
1	Constipation 01/2021
1	Jet Lag Syndrome 01/2019
1	Glucose Intolerance 01/2019

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 01/2021 - 01/2006
16	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 03/2003
13	Serotonin ReceptorsIBA 01/2022 - 12/2001
10	LigandsIBA 10/2022 - 08/2010
9	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 12/2001
7	Opioid Analgesics (Opioids)IBA 01/2021 - 09/2002
6	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2014
5	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 01/2016
5	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 01/2010
4	Antidepressive Agents (Antidepressants)IBA 01/2019 - 11/2009
4	Clozapine (Clozaril)FDA LinkGeneric 01/2016 - 04/2005
4	Opioid Receptors (Opioid Receptor)IBA 01/2016 - 03/2012
4	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 10/2011 - 09/2003
3	Hallucinogens (Psychedelics)IBA 01/2022 - 11/2009
3	GTP-Binding Proteins (G-Protein)IBA 01/2021 - 01/2015
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 07/2008
3	Dopamine (Intropin)FDA LinkGeneric 10/2017 - 02/2004
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 08/2004
3	salvinorin AIBA 10/2006 - 09/2002
2	Psilocybin (Psilocibin)IBA 01/2022 - 01/2020
2	EnzymesIBA 01/2022 - 01/2020
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2021 - 01/2021
2	Famotidine (Pepcid)FDA LinkGeneric 01/2021 - 06/2020
2	ArrestinIBA 01/2021 - 01/2016
2	Histamine Receptors (Histamine Receptor)IBA 01/2021 - 06/2020
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2019 - 09/2002
2	5-HT2C Serotonin ReceptorIBA 01/2018 - 08/2010
2	Praziquantel (Biltricide)FDA Link 12/2017 - 01/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2017 - 02/2011
2	lorcaserinIBA 10/2017 - 12/2013
2	Serotonin 5-HT2 Receptor AgonistsIBA 10/2017 - 01/2016
2	Amphetamine (Amfetamine)FDA LinkGeneric 10/2017 - 01/2016
2	Haloperidol (Haldol)FDA LinkGeneric 01/2016 - 09/2014
2	Peptides (Polypeptides)IBA 03/2015 - 12/2014
2	pimavanserinIBA 12/2013 - 12/2008
2	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 03/2011 - 03/2003
2	Anti-Anxiety Agents (Anxiolytics)IBA 12/2010 - 11/2009
2	Caveolin 1IBA 11/2009 - 08/2004
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 02/2006 - 01/2005
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2022
1	KynurenineIBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	Pramipexole (Mirapex)FDA LinkGeneric 01/2021
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2021
1	Apomorphine FDA Link 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	Methadone (Dolophine)FDA LinkGeneric 01/2021
1	3,4,4a,10b- tetrahydro- 4- propyl- 2H,5H- (1)benzopyrano(4,3- b)- 1,4- oxazin- 9- olIBA 01/2021
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2021
1	VaccinesIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	BenzodiazepinesIBA 01/2019
1	2-phenylmelatoninIBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Glucagon (Glukagon)FDA Link 01/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2003
4	Analgesia 01/2021 - 01/2015
2	Lasers (Laser) 01/2019 - 01/2019